Altria posted negative quarterly operating cash flow against $1.5B in dividend outflows, while Pfizer's $0.77 EPS can't cover its $1.72 annual payout. When executives emphatically insist a dividend is safe under obvious stress, treat that defense as a warning signal, not a green light. LyondellBasell's operating cash flow collapsed from $4.9B to $2.3B in two years, and another dividend cut is possible if the chemical cycle stalls.
Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Pfizer didn't make the cut. Enter your email to see the names that beat PFE. Enter your email and see if any of your stocks made the cut.
Income investors chasing a fat headline yield often step into the same trap: a payout the underlying business no longer generates enough cash to cover. A dividend is only as safe as the coverage math behind it, and the right coverage math depends on the structure. Earnings and free cash flow work for ordinary corporates.
Equity REITs need FFO or AFFO. MLPs run on distributable cash flow. When any of those come up short, the yield is a warning.
None of the names below have announced a cut. Each shows specific strain worth watching, the same category of red flags we walked through in a free report on the seven signs a big yield is about to be cut. Altria (NYSE:MO) just raised its quarterly payout to $1.11 from $1.06, pushing the annualized forward dividend to $4.44.
On a market cap of roughly $114.9 billion and a share price of $68.50, the yield sits in ultra-high-yield territory. 24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about.
Extract — continue reading at the source.
